<?xml version="1.0" encoding="UTF-8"?>
<p>PVB19 affects 1â€“5 % of pregnant women with most women having a normal pregnancy outcome (Ergaz and Ornoy 
 <xref ref-type="bibr" rid="CR21">2006</xref>). There are documented relationships with fetal deaths secondary to possible fetal anemia with resultant fetal high-output cardiac failure and nonimmune hydrops fetalis (Adler and Koch 
 <xref ref-type="bibr" rid="CR1">2011</xref>). Intrauterine PVB19 has an affinity for the P antigen expressed on fetal cardiac myocytes leading to cardiac failure from direct or indirect or autoimmune damage (Bowles et al 
 <xref ref-type="bibr" rid="CR9">2003</xref>). There have been isolations of PVB19 in children and adults with unexplained fulminant hepatitis. These patients had a low bilirubin level, no jaundice, and recovered rapidly. Serum high values of AST and ALT normalized in 3 weeks (Huang et al. 
 <xref ref-type="bibr" rid="CR27">2012</xref>).
</p>
